The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Quinolines, a perpetual, multipurpose scaffold in medicinal chemistry
Abstract
Quinoline is a versatile pharmacophore, a privileged scaffold and an outstanding fused heterocyclic compound with a wide range of pharmacological prospective such as anticancer, anti-inflammatory, antibacterial, antiviral drug and superlative moiety in drug discovery. The quinoline hybrids have already been shown excellent results with new targets with a different mode of actions as an inhibitor of cell proliferation by cell cycle arrest, apoptosis, angiogenesis, disruption of cell migration and modulation. This review emphasized the mode of action, structure activity relationship and molecular docking to reveal the various active pharmacophores of quinoline hybrids accountable for novel anticancer, anti-inflammatory, antibacterial and miscellaneous activities. Therefore, several quinoline candidates are under clinical trials for the treatment of certain diseases, for example ferroquine (antimalarial), dactolisib (antitumor) and pelitinib (EGFR TK inhibitors) etc. Plenty of research has been summarized the recent advances of quinoline derivatives and explore the various therapeutic prospects of this moiety. This review would help the researchers to strategically design diverse novel quinoline derivatives for the development of clinically viable drug candidates for the treatment of incurable diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A review on anticancer potential of bioactive heterocycle quinoline
Afzal, O., Kumar, S., Haider, M. R., Ali, M. R., Kumar, R., Jaggi, M., & Bawa, S. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.044 · Cited by 798
Comprehensive review on current developments of quinoline-based anticancer agents
Jain, S., Chandra, V., Kumar Jain, P., Pathak, K., Pathak, D., & Vaidya, A. (2019) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2016.10.009 · Cited by 394
Abou-Alfa, G. K., Letourneau, R., Harker, G., Modiano, M., Hurwitz, H., Tchekmedyian, N. S., Feit, K., Ackerman, J., De Jager, R. L., Eckhardt, S. G., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.0201 · Cited by 282
An overview of quinoline as a privileged scaffold in cancer drug discovery
Musiol, R. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1319357 · Cited by 246
The antimalarial ferroquine: from bench to clinic
Biot, C., Nosten, F., Fraisse, L., Ter-Minassian, D., Khalife, J., & Dive, D. (2011) · Parasite · doi:10.1051/parasite/2011183207 · Cited by 180
Mitsui, I., Kumazawa, E., Hirota, Y., Aonuma, M., Sugimori, M., Ohsuki, S., Uoto, K., Ejima, A., Terasawa, H., & Sato, K. (1995) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1995.tb02468.x · Cited by 165
Frankel, J. S., & Schwartz, T. L. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316672136 · Cited by 145
Katariya, K., Shah, S. R., & Reddy, D. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103406 · Cited by 129
Ramírez–Prada, J., Robledo, S. M., Vélez, I. D., Crespo, M. D. P., Jairo Quiroga, P., Abonía, R., Montoya, A. L., Svetaz, L. A., Zacchino, S. A., & Braulio Insuasty, O. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.03.016 · Cited by 127
Mechanism of action of brexpiprazole: comparison with aripiprazole
Stahl, S. M. (2016) · CNS Spectrums · doi:10.1017/s1092852915000954 · Cited by 116
Bendell, J. C., Kurkjian, C. D., Infante, J. R., Bauer, T. M., Burris, H. A., Greco, F. A., Shih, K. C., Thompson, D. S., Lane, C. M., Finney, L. H., et al. (2015) · Investigational New Drugs · doi:10.1007/s10637-015-0218-6 · Cited by 101
George, R. F., Samir, E. M., Abdelhamed, M. N., Abdel‐Aziz, H. A., & Abbas, S. E.-S. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.10.038 · Cited by 99
Nikookar, H., Mohammadi‐Khanaposhtani, M., Imanparast, S., Faramarzi, M. A., Ranjbar, P. R., Mahdavi, M. R., & Larijani, B. A. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.01.025 · Cited by 97
Fedorowicz, J., Sączewski, J., Konopacka, A., Waleron, K., Lejnowski, D., Ciura, K., Tomašič, T., Skok, Ž., Savijoki, K., Morawska, M., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.06.071 · Cited by 87
Farooqi, S. I., Arshad, N., Channar, P. A., Perveen, F., Saeed, A., Larik, F. A., & Javeed, A. (2018) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2018.10.006 · Cited by 85
Anti-proliferative effects of copper(II) complexes with hydroxyquinoline-thiosemicarbazone ligands
Rogolino, D., Cavazzoni, A., Gatti, A. M., Tegoni, M., Pelosi, G., Verdolino, V., Fumarola, C., Cretella, D., Petronini, P. G., & Carcelli, M. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.01.031 · Cited by 83
Qin, Q., Wang, Z., Huang, X., Tan, M., Zou, B., & Liang, H. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111751 · Cited by 76
Liberto, N. A., Simões, J. B., Silva, S. D. P., da-Silva, C. J., Modolo, L. V., de Fátima, Â., Silva, L. M., Derita, M., Zacchino, S. A., Zúñiga, O. M. P., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.12.023 · Cited by 73
Krawczyk, M., Pastuch-Gawołek, G., Mrozek‐Wilczkiewicz, A., Kuczak, M., Skonieczna, M., & Musioł, R. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.11.047 · Cited by 71
Mohassab, A. M., Hassan, H. A., Abdelhamid, D. S., Abdel‐Aziz, M., Dalby, K. N., & Kaoud, T. S. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.09.018 · Cited by 70
Design, Synthesis and Anticancer Evaluation of New Substituted Thiophene-Quinoline Derivatives
Othman, D. I. A., Selim, K. B., El‐Sayed, M. A. ‐., Tantawy, A. S., Amen, Y. M., Shimizu, K., Okauchi, T., & Kitamura, M. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.07.042 · Cited by 66
Ribeiro, A. G., de Almeida, S. M. V., de Oliveira, J. F., Souza, T. R. C. D. L., dos Santos, K. L., Albuquerque, A. P. D. B., Nogueira, M. C. D. B. L., de Carvalho, L. B., de Moura, R. O., da Silva, A. C., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111592 · Cited by 64
Alagumuthu, M., & Arumugam, S. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.01.007 · Cited by 63
Ramachandran, E., Gandin, V., Bertani, R., Sgarbossa, P., Natarajan, K., Bhuvanesh, N. S. P., Venzo, A., Zoleo, A., Glisenti, A., Dolmella, A., et al. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.01.016 · Cited by 60
Quinolidene-rhodanine conjugates: Facile synthesis and biological evaluation
Subhedar, D. D., Shaikh, M. H., Shingate, B. B., Nawale, L., Sarkar, D. M., Khedkar, V. M., Khan, F. A. K., & Sangshetti, J. N. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.059 · Cited by 57
Kwon, S., Lee, Y., Jung, Y.-E., Kim, J. H., Baek, B., Lim, B., Lee, J., Kim, I., & Lee, J. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.016 · Cited by 57
Prashanth, T., Avin, B. R. V., Thirusangu, P., Ranganatha, V. L., Prabhakar, B. T., Chandra, J. N. N. S., & Khanum, S. A. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108707 · Cited by 54
Cytotoxicity of 4-substituted quinoline derivatives: Anticancer and antileishmanial potential
Costa, C. A., Lopes, R. D. M., Ferraz, L. S., Esteves, G. N. N., Iório, J. F. D., de Souza, A. A., de Oliveira, I. M., Manarin, F., Júdice, W. A. D. S., Stefani, H. A., et al. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115511 · Cited by 52
Su, T., Zhu, J., Sun, R., Zhang, H., Huang, Q., Zhang, X., Du, R., Qiu, L., & Cao, R. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.05.088 · Cited by 50
Ahadi, H., & Emami, S. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111970 · Cited by 50
Akkachairin, B., Rodphon, W., Reamtong, O., Mungthin, M., Tummatorn, J., Thongsornkleeb, C., & Ruchirawat, S. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103732 · Cited by 47
3H-pyrazolo[4,3-f]quinoline haspin kinase inhibitors and anticancer properties
Opoku‐Temeng, C., Dayal, N., Sooreshjani, M. A., & Sintim, H. O. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.03.031 · Cited by 46
Chelli, S. M., Alagumuthu, M., Sridhar, P., Sivakumar, A., Belliraj, S. K., & Reddy, S. R. (2017) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2017.10.075 · Cited by 45
To, K. K. W., Poon, D. C., Wei, Y., Wang, F., Lin, G., & Fu, L. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13189 · Cited by 44
Aly, A. A., El‐Sheref, E. M., Bakheet, M. E. M., Mourad, M. A. E., Brown, A. B., Bräse, S., Nieger, M., & Ibrahim, M. A. A. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.09.017 · Cited by 43
Debnath, U., Mukherjee, S., Joardar, N., Babu, S. P. S., Jana, K., & Misra, A. K. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.016 · Cited by 43
Design, synthesis and biological evaluation of tetrahydroquinoline-based reversible LSD1 inhibitors
Wang, X., Zhang, C., Zhang, X., Yan, J., Wang, J., Jiang, Q., Zhao, L., Zhao, D., & Cheng, M. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112243 · Cited by 42
Jitender Dev, G., Poornachandra, Y., Kuchukulla, R. R., Kumar, R., Ravikumar, N., Swaroop, D. K., Ranjithreddy, P., Kumar, G. S., Nanubolu, J. B., Kumar, C. G., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.02.052 · Cited by 41
Dayal, N., Mikek, C. G., Hernandez, D. E., Naclerio, G. A., Chu, E. F. Y., Carter‐Cooper, B., Lapidus, R. G., & Sintim, H. O. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.06.089 · Cited by 40
Novel ruthenium azo-quinoline complexes with enhanced photonuclease activity in human cancer cells
Kaulage, M. H., Maji, B., Pasadi, S., Bhattacharya, S., & Muniyappa, K. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.08.059 · Cited by 38
Cao, W., Qi, J., Qian, K., Tian, L., Cheng, Z., & Wang, Y. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.11.017 · Cited by 38
Singh, K., Verma, V., Yadav, K., Sreekanth, V., Kumar, D., Bajaj, A., & Kumar, V. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.055 · Cited by 36
Thangaraj, M., Gengan, R. M., Ranjan, B., & Ramesh, M. (2017) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2017.11.019 · Cited by 36
Ramya, P., Guntuku, L., Angapelly, S., Karri, S., Digwal, C. S., Babu, B. N., Naidu, V. G. M., & Kamal, Ä. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.01.070 · Cited by 35
Kwak, S., Shin, S., Lee, J.-H., Shim, J., Kim, M.-J., Lee, S., Lee, A., Bae, J., Park, J.-H., Abdelrahman, A., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.023 · Cited by 34
Kuang, W., Huang, R.-Z., Qin, J.-L., Lü, X., Qin, Q., Zou, B., Chen, Z., Liang, H., & Zhang, Y. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.07.066 · Cited by 34
Chagas, C. D. S., Fonseca, F. L. A., & Bagatin, I. A. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.01.058 · Cited by 33
Xu, C., Han, Y., Xu, S., Wang, R., Yue, M., Tian, Y., Li, X., Zhao, Y., & Gong, P. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111867 · Cited by 31
Shu, B., Zeng, P., Kang, S., Li, P., Hu, D.-X., Kuang, G., Cao, J., Li, X., Zhang, M., An, L., et al. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.12.020 · Cited by 30
Yang, R., Chen, Y., Pan, L., Yang, Y., Zheng, Q., Hu, Y., Wang, Y., Zhang, L., Sun, Y., Li, Z., et al. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.08.028 · Cited by 27
Rivas, F., Medeiros, A., Comini, M. A., Suescun, L., Arce, E. R., Martins, M., Pinheiro, T., Marques, F., & Gambino, D. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.110779 · Cited by 26
Kayarmar, R., Nagaraja, G. K., Naik, P., Manjunatha, H., Revanasiddappa, B. C., & Arulmoli, T. (2014) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2014.07.003 · Cited by 25
Vesnarinone: A new inotropic agent for treating congestive heart failure
Çavuşoğlu, E., Frishman, W. H., & Klapholz, M. (1995) · Journal of Cardiac Failure · doi:10.1016/1071-9164(95)90030-6 · Cited by 25
Banu, S., Bollu, R., Bantu, R., Nagarapu, L., Polepalli, S., Jain, N., Vangala, R., & Manga, V. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.062 · Cited by 25
Nepali, K., Lin, M.-H., Chao, M., Peng, S.-J., Hsu, K., Lin, T. E., Chen, M.-C., Lai, M.-J., Pan, S., & Liou, J. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103119 · Cited by 22
Omotehara, F., Kawamata, H., Uchida, D., Hino, S., Nakashiro, K., & Fujimori, T. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600592 · Cited by 19
Lü, X., Wu, Y., Yang, J., Ma, F.-E., Li, L., Chen, S., Zhang, Y., Ni, Q., Pan, Y., Hong, X., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.074 · Cited by 19
Luchese, C., Barth, A., da Costa, G. P., Alves, D. A. C., Novo, D. L. R., Mesko, M. F., & Wilhelm, E. A. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110804 · Cited by 19
Li, B., Zhu, F., He, F., Huang, Q., Liu, X., Wu, T., Zhao, T., Qiu, Y., Wu, Z., Xue, Y., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103592 · Cited by 19
Duroux, R., Rami, M., Landagaray, E., Ettaoussi, M., Caignard, D., Delagrange, P., Melnyk, P., & Yous, S. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.025 · Cited by 18
Shahin, M. I., Roy, J., Hanafi, M., Wang, D., Luesakul, U., Chai, Y., Muangsin, N., Lasheen, D. S., Ella, D. A. A. E., Abouzid, K. A. M., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.05.042 · Cited by 18
Insuasty, D., Robledo, S. M., Vélez, I. D., Cuervo, P. A., Braulio Insuasty, O., Jairo Quiroga, P., Nogueras, M., Cobo, J., & Abonía, R. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.024 · Cited by 17
Valdivieso, E., Mejías, F., Torrealba, C., Benaím, G., Kouznetsov, V. V., Sojo, F. J., Rojas-Ruiz, F. A., Arvelo, F. A., & Dagger, F. (2018) · Acta Tropica · doi:10.1016/j.actatropica.2018.03.023 · Cited by 17
Drogosz-Stachowicz, J., Długosz-Pokorska, A., Gach, K., Jaskulska, A., Janecki, T., & Janecka, A. E. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109005 · Cited by 15
Bortolozzi, R., Mattiuzzo, E., Prà, M. D., Sturlese, M., Moro, S., Hamel, E., Carta, D., Viola, G., & Ferlin, M. G. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.11.038 · Cited by 13
Potočňák, I., Drweesh, E. A., Kuchárová, V., Lüköová, A., Sabolová, D., Radojević, I. D., Arsenijević, A., Djordjevic, D., & Volarević, V. (2017) · Polyhedron · doi:10.1016/j.poly.2017.07.008 · Cited by 12
Zhang, W., Li, P., Zhao, M.-C., Gu, Y.-H., Dong, C., Chen, H., & Du, Z. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.03.073 · Cited by 12
Xiao, X., Li, S., Zhang, X., Lu, J., Wang, W., Zhou, S., Zhang, J., Wang, R., & Li, A. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.04.017 · Cited by 12
Kuchárová, V., Kuchár, J., Zarić, M., Čanović, P. P., Arsenijević, N., Volarević, V., Misirkic-Marjanovic, M., Trajković, V., Radojević, I. D., Čomić, L. R., et al. (2019) · Inorganica Chimica Acta · doi:10.1016/j.ica.2019.119062 · Cited by 11
Sobhanifar, M.-A., Mashkani, B., Saadatmandzadeh, M., Sadeghnia, H. R., & Mousavi, S. H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.001 · Cited by 4
Drugs used in ocular treatment
Schouten, J. (2012) · Side effects of drugs annual · doi:10.1016/b978-0-444-59499-0.00047-7 · Cited by 1
Drugs used in ocular treatment
Schouten, J. (2010) · Side effects of drugs annual · doi:10.1016/s0378-6080(10)32047-2 · Cited by 1
Cited by
Ryad, N., Elmaaty, A. A., Selim, S., Almuhayawi, M. S., Al Jaouni, S. K., Abdel-Aziz, M. S., Alqahtani, A. S., Zaki, I., & Abdel Ghany, L. M. A. (2024) · RSC Advances · doi:10.1039/d4ra06712f · Cited by 13
Metadata
- Authors
- Yadav, P., & Shah, K.
- Venue
- Bioorganic Chemistry
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 109
- Pages
- 104639
- ISSN
- 0045-2068 (ISSN-L)
- OpenAlex
- W3120498776
- Cited by
- 286
- References
- 72
- FWCI
- 15.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.